The results from this randomized controlled trial demonstrated that the simple and welltolerated application of RIPC in patients at risk of renal dysfunction undergoing CA reduced the incidence of procedure-related CIN. Thus, the use of RIPC may be a feasible therapeutic procedure and a large study on high-risk patients should be performed to assess the effect of RIPC as an alternate to hydration to provide additional protection in these high-risk patients